Isotretinoin - oral

Indication

Acne

MHRA Drug Safety Update - Isotretinoin (Roaccutane): reminder of possible risk of psychiatric disorders

MHRA Drug Safety Update - Oral retinoids: pregnancy prevention—reminder of measures to minimise teratogenic risk

MHRA Drug Safety Update - Isotretinoin: risk of serious skin reactions

MHRA Drug Safety Update - Isotretinoin for severe acne: who should prescribe it

MHRA Drug Safety Update - Isotretinoin: new safety measures to be introduced in the coming months, including additional oversight on initiation of treatment for patients under 18 years

Red

Brand:

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

BNF chapter:

Skin

Background

As a RED drug, isotretinoin should be supplied by secondary care. Local exceptions to this are for patients under the care of the consultant-led integrated community dermatology service, OMNES.

 Community pharmacies can dispense FP10s for isotretinoin from OMNES where it is clear that the prescription has been issued within the context of a Pregnancy Prevention Programme. Do not dispense 7 days beyond issue date of FP10. Please refer the pharmacy checklist and  Isotretinoin (Roaccutane▼): introduction of new safety measures, including additional oversight of the initiation of treatment for patients under 18 years of age

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Decisions of Lancashire local decision making groups

BwD	BP	CSR	EL	FW	GP	MB	WL
Red	Red	Red	Red	Red	Red	Red	Red

What do the colours mean?

Last Updated: 01 - May - 2013